EP Patent

EP2816043A1 — Spherical ticagrelor particles

Assigned to Lek Pharmaceuticals dd · Expires 2014-12-24 · 11y expired

What this patent protects

The present invention relates to crystalline ticagrelor in form of spherical particles, to processes of preparing the same and to the use of the spherical particles for the preparation of a pharmaceutical composition.

USPTO Abstract

The present invention relates to crystalline ticagrelor in form of spherical particles, to processes of preparing the same and to the use of the spherical particles for the preparation of a pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
EP2816043A1
Jurisdiction
EP
Classification
—
Expires
2014-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Lek Pharmaceuticals dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.